Glutaric aciduria type II: Observations in seven patients with neonatal- and late-onset disease

Journal of Perinatology

Volumn 20, Issue 2, 2000, Pages 120-128

  Al Essa, Mohammed A ^a   Rashed, Mohamed S ^a   Bakheet, Siema M ^a   Patay, Zoltan J ^a   Ozand, Pinar T ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE; DRUG DERIVATIVE; GLUTARIC ACID; GLUTARIC ACID DERIVATIVE;

ACIDOSIS; ARTICLE; BRAIN; CASE REPORT; CEREBROSPINAL FLUID; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSANGUINITY; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; INFANT; MALE; MASS SPECTROMETRY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOLOGY; SCINTISCANNING; URINE;

ACIDOSIS; AGE OF ONSET; BRAIN; CARNITINE; CHILD; CONSANGUINITY; FEMALE; GLUTARATES; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; MASS SPECTROMETRY; METABOLISM, INBORN ERRORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034152434     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200325     Document Type: Review

References (33)

1. Frerman FE, Goodman SI. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia type II. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw Hill Inc; 1995. p. 1611-29.
2. Ozand PT, Gascon GG. Organic acidurias: a review. Part I. J Child Neurol 1991; 6:196-219.
3. Vianey-Liaud C, Divry P, Gregersen N, Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis 1987;10(Suppl 1):159-200.
4. Goodman SI, Reale M, Berlow S. Glutaric acidemia type II: a form with deleterious intrauterine effects. J Pediatr 1983;102:411-3.
5. Mitchell G, SaudubrayJM, Gubler MC, et al. Congenital anomalies in glutaric aciduria type 2. J Pediatr 1984;104:961-2.
6. Lehnert W, Wendel U, Lindenmaier S, Bohm N. Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers: clinical, metabolical, and biochemical findings. Eur J Pediatr 1982;139:56-9.
7. Hoganson G, Berlow S, Gilbert EF, Frerman F, Goodman S, Schweitzer L Glutaric acidemia type II and flavin-dependent enzymes in morphogenesis. Birth Defects Orig Artic Ser 1987;23:65-74.
8. Bennett MJ, Pollitt RJ, Land JM, Turner MJ, Cheetham CH. Lethal multiple acylCoA dehydrogenation deficiency with dysmorphic features. J Inherit Metab Dis 1987;10:95-6.
9. Coude FX, Ogier H, Charpentier C, et al. Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder. Hum Genet 1981;59:263-5.
10. Harkin JC, Gill WL, Shapira E. Glutaric acidemia type II: phenotypic findings and ultrastructural studies of brain and kidney. Arch Pathol Lab Med 1986;110:399-401.
11. Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM. Glutaric aciduria type II: comparison of pathologic features in two infants. Arch Pathol Lab Med 1988;112:1133-9.
12. Goodman SI, Stene DO, McCabe ER, et al. Glutaric acidemia type II: clinical, biochemical, and morphologic considerations. J Pediatr 1982;100:946-50.
13. Bohm N, Uy J, Kiessling M, Lehnert W. Multiple acyl CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polyeystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 1982;139:60-5.
14. Gregersen N, Kolvraa S, Rasmussen K, et al. Biochemical studies in a patients with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. J Inherit Metab Dis 1980;3:67-72.
15. Sweetman L, Nyhan WL, Tauner DA, Merritt TA, Singh M. Glutaric aciduria type II. J Pediatr 1980;96:1020-6.
16. Goodman SI, Frerman FE. Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency). J Inherit Metab Dis 1984;7(Suppl 1)33-7.
17. Chalmers RA, Tracey BM, King GS, et al. The prenatal diagnosis of glutaric aciduria type II, using quantitative GC-MS. J Inherit Metab Dis 1985;8(Suppl 2): 145-6.
18. Tanaka K, Mantagos S, Genel M, Seashore MR, Billings BA, Baretz BH. New defect in fatty-acid metabolism with hypoglycemia and organic aciduria. Lancet 1977; 2:986-7.
19. Dusheiko G, Kew MC, Joffe BI, Lewin JR, Mantagos S, Tanaka K. Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. N Engl J Med 1979;301:1405-9.
20. Verjee ZH, Sherwood WG. Multiple acyl-CoA dehydrogenase deficiency: a neonatal onset case responsive to treatment. J Inherit Metab Dis 1985;8(Suppl 2):137-8.
21. Gregersen G, Wintzensen H, Christensen SK, Christensen MF, Brandt NJ, Rasmussen K. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin-responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res 1982;16: 861-8.
22. Rashed MS, Ozand PT, Harrison ME, Watkins PJ, Evans S. Electrospray tandem mass spectrometry in the diagnosis of organic acidemias. Rapid Commun Mass Spectrom 1994;8:129-33.
23. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
24. Ozand PT, Gascon GG. Organic acidurias: a review. Part 2. J Child Neurol 1991;6: 288-303.
25. Chugani HT. Functional brain imaging in pediatrics. Pediatr Clin North Am 1992:39:777-99.
26. Bennett MJ, Curnock DA, Engel PC, et al. Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally. J Inherit Metab Dis 1984;7:57-61.
27. Mitchell G, SaudubrayJM, Benoit Y, et al. Antenatal diagnosis of glutaric aciduria type II. Lancet 1983;1:1099.
28. Jakobs C, Sweetman L, Wadman SK, Duran M, SaudubrayJM, Nyhan VL. Prenatal diagnosis of glutaric aciduria type II by direct analysis of dicarboxylic acids in amniotic fluid. EurJ Pediatr 1984;141:153-7.
29. Yamaguchi S, Shimizu N, Orii T, et al. Prenatal diagnosis and neonatal monitoring of a fetus with glutaric aciduria type II due to electron transfer flavoprotein (β-subunit) deficiency. Pediatr Res 1991;30:439-43.
30. de Visser M, Scholte HR, Schutgens RB, et al. Riboflavin-responsive lipid-storage myopathy and glutaric aciduria type 11 of early adult onset. Neurology 1986;36: 367-72.
31. Mooy PD, Przyrembel H, Giesberts MA, Scholte HR, Blom W, van Gelderen HH. Glutaric aciduria type II: treatment with riboflavin, carnitine, and insulin. Eur J Pediatr 1984;143:92-5.
32. HarpeyJP, Charpentier C, Goodman SI, Darbois Y, Lefebvre G, Sebbah J. Multiple acyl-CoA dehydrogenase deficiency occurring in pregnancy and caused by a defect in riboflavin metabolism in the mother. Study of a kindred with seven deaths in infancy: value of riboflavin therapy in preventing this syndrome. J Pediatr 1983;103:394-8.
33. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw Hill Inc; 1995. p. 1501-33.